| Tag | Content |
|---|
EnhancerAtlas ID | HS054-00257 |
Organism | Homo sapiens |
Tissue/cell | FT246 |
Coordinate | chr1:60143210-60145230 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr1:60144580-60144598 | CAGACCTTCCTTCCTCCC | - | 6.11 | | GATA2 | MA0036.3 | chr1:60144340-60144351 | TTCTTATCTTC | + | 6.02 | | ONECUT2 | MA0756.1 | chr1:60144102-60144116 | GGAAAATCAATAAA | + | 6.25 | | ONECUT3 | MA0757.1 | chr1:60144102-60144116 | GGAAAATCAATAAA | + | 6.72 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_51437 | chr1:60142976-60145130 | Skeletal_Muscle | | SE_51991 | chr1:60142971-60145302 | Skeletal_Muscle_Myoblast | | SE_63797 | chr1:60142878-60145316 | HSMM |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I059677 | chr1 | 60143487 | 60145290 |
|
Enhancer Sequence | CTTGAGGAGA CAGGGTTTTC ATAGGCCCCT GAATGGATGA TTTTCAGCCG GGGGTAGAGT 60
CCTATACCTT TCTTGGGTGA TACCAATGGA TCCACAGCTG TAGATTTTAC TTGTAGCTTT 120
TGTAGACTCT GTGTATCTCA ATTCTGGGAG AATTTTATCA GGGGAAGGGA GACTGGATGG 180
AATATTCTGG TGGGCCCTTA ATGAAAGATT GGCCAACAAC AAGATCTATT GATATTGCAA 240
ATTTTGAAAC ATGCTGACAA TTCCTAGCTT CCTTCTTTTG TTCTTTTATC CATTCAGATT 300
CTCCTTCTCT TAGTTTGTCT CTGTCTCTCT TCCCTTGTCC TTTCCTGCTC TCTCTCTCCC 360
TTTAGACATC TAAAGTCTTC TTACTATTTC TTTGTCAAAT TCGGATCTCA CAAAGGATAC 420
TGACATAGCC ATTCGTTCAT TCTAAAGAAT ACAATGACTA ATACTATCTT AAAGAGTTGC 480
CCCTCTTTAG AAAGGGTGTT TTCCTTTTAG TAGTTTTCAA AACTGTGTCT TTACTAAAGA 540
GAACAGTCTC CTTGTGGACA AGTATTCTTG AAGGCAAATC ATGATCAGCT TTATATCTGC 600
GGTTTAATGA AAAATATGGA ATCAAGCCAC AGATATGCTG CTCTCACAGT AAAAATTTAG 660
CTATTGAATA AGTGGGAGGG GACACAAAGA AGGCAGTTCA CTTCCCCTCC CTTTACTCTT 720
AGGAATGTGG AATCCCTGCA GTCTTGACCT CTGTGACCTT TCTACTTGAT CCCTCCCCCA 780
TCATCAGTAG AGTACAAAAT GATCCTCTGT AATTCTGAAT ATCTTGGAAA ACAAATAATT 840
ATAATTAGAA GCTGAGAGTG TTCCATAACA CTTCTCTAGG CTCCCAGGTC CTGGAAAATC 900
AATAAACTGG AAAAAAACTA AGTTTATGAA ATATCACTAT GCTTACACTT TCTAAGCACA 960
GACAGTTAAA AGATTCTAAG AAATACAAGG ACAAATAAAT AAAACAAGAA GCAGTTTCAA 1020
GTCGTTGTGA GAGAAAACTC AATCAAATGG CAAAGAGACA GCAACATGAA ATGGCTCTCC 1080
ACTTTCTGTT TCCTTCAGGC CCCCTGCAGA TGTCATTAGC TTTCTGTAAT TTCTTATCTT 1140
CAGGGGCAGT TTTTATTCAA GTCTATTTAG ACAAAACAAG CTTTAATTCC AGCAGTGCTA 1200
TTTGTCTTGA ACCACCACCC CCCACCCTTG AAAAAAAGGA GTGGAGGAAG CATCTGAAGC 1260
AAAAATCAGT AAAAGGAGAC AGTGACAAGA GATCAAAATG CATTCAGCAG TCATTTTAAG 1320
GGGAGTACCA GTGTAAAGAA AATAAGCCCT TGGAATCAGC CAATTAATCA CAGACCTTCC 1380
TTCCTCCCAC TGTGTGAGTG TTGCCACCCC TGTAAACCAC TGACTCCATG CACTCTCACC 1440
ATCAACTTTC CCTGTCACGT TCCAGACAGA CTCCTGTGTC TTCAAGACCA ATACATGTAA 1500
GTGGCCAGTT GAGAGCTGTG ATTACTCACC CTTTCTGTAA TGTGTGCCCA CAAGATAAAC 1560
CATCCATGCT GACCGCAGTG GTCTACCCTT GAGGTCATTC CTTGCAAACA TCCTCATTGC 1620
TTAGCTGAAA CCTCTACTTC TGTTCTTTTT CATGAAATTC ACTTCATTTA GGGCCAGTTA 1680
TACTCATCAC CTGTTATGCA TTTCAGAGCC TATGATTTTT GTATATAACA TGTCTCCCAT 1740
TCTATTTTAT TTTGTAAGAG TCAACTTTCT GTGATTTTTT TTTTTAGCTC TATTTGGCTT 1800
TCTGTCACGA TAAATAACAG TTTTGCTATT TGCAAAATAA AGCTGATTAT CATTATTTTA 1860
GTTTCCAGAG GTTAGAAAAA ACTGAAATAC CGTAGATGTT CAGAAGTATG AAACCATCCC 1920
ATTTCTCGGT GCATTCAATT TAGTTTACTT GCATTTTTTT CTTTGTCTGG AATACTAACA 1980
TTTCATGTTC ATTGGGGACA AAAATAAGAA AATTTAATTA 2020
|
